Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin
- 6 March 2003
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 88 (6) , 1188-1201
- https://doi.org/10.1002/jcb.10460
Abstract
The plasminogen/plasmin system is involved in vascular wall remodeling after injury, through extracellular matrix (ECM) degradation and proteinase activation. Vascular smooth muscle cells (VSMCs) synthesize various components of the plasminogen/plasmin system. We investigated the conversion of plasminogen into plasmin in primary cultured rat VSMCs. VSMCs efficiently converted exogenous plasminogen into plasmin in a time- and dose-dependent manner. We measured plasmin activity by monitoring the hydrolysis of Tosyl-G-P-R-Mca, a fluorogenic substrate of plasmin. Cell-mediated plasmin activation was associated with the degradation of ECM, as revealed by fibronectin proteolysis. Plasmin also activated a proteinase able to hydrolyze Mca-P-L-G-L-Dpa-A-R-NH2, a fluorogenic substrate of matrix metalloproteinases (MMPs). However, this proteinase was not inhibited by an MMP inhibitor. Furthermore, this proteinase displayed similar biochemical and pharmacological properties to fibronectin-proteinase, a recently identified zinc-dependent metalloproteinase located in the gelatin-binding domain of fibronectin. These results show that VSMCs convert exogenous plasminogen into plasmin in their pericellular environment. By hydrolyzing matrix protein plasmin activates a latent metalloproteinase that differs from MMP, fibronectin-proteinase. This metalloproteinase may participate to vascular wall remodeling, in concert with other proteinases. J. Cell. Biochem. 88: 1188–1201, 2003.Keywords
This publication has 39 references indexed in Scilit:
- Purification and Characterization of A61Published by Elsevier ,2001
- Inactivation of Plasminogen Activator Inhibitor-1 by Specific Proteolysis with Stromelysin-1 (MMP-3)Journal of Biological Chemistry, 2000
- Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant ResistancePublished by Elsevier ,1999
- Generation of Angiostatin by Reduction and Proteolysis of PlasminPublished by Elsevier ,1997
- PROTEOGLYCAN-DEGRADING ACTIVITY ASSOCIATED WITH THE 40 kDa COLLAGEN-BINDING FRAGMENT OF FIBRONECTINRheumatology, 1996
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: A key event in melanoma cell invasiveness in vitroExperimental Cell Research, 1992
- A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinasesFEBS Letters, 1992
- Collagen‐binding domain of human plasma fibronectin contains a latent type‐IV collagenaseEuropean Journal of Biochemistry, 1991
- Binding of Lys-plasminogen to monocytes/macrophages.Journal of Clinical Investigation, 1988